Background and Purpose-Hyponatremia is the most frequent electrolyte disturbance in critical care. Across various disciplines, hyponatremia is associated with increased mortality and longer hospital stay, yet in intracerebral hemorrhage (ICH) no data are available. This the first study that investigated the prevalence and clinical associations of hyponatremia in patients with ICH. Methods-This observational study included all consecutive spontaneous ICH patients (n=464) admitted during a 5-year period to the Department of Neurology. Patient characteristics, in-hospital measures, mortality, and functional outcome (90 days and 1 year) were analyzed to determine the effects of hyponatremia (Na <135 mEq/L). Multivariable regression analyses were calculated for factors associated with hyponatremia and predictors of in-hospital mortality. Results-The prevalence of hyponatremia on hospital admission was 15.6% (n=66). Normonatremia was achieved and maintained in almost all hyponatremia patients <48 hours. In-hospital mortality was roughly doubled in hyponatremia compared with nonhyponatremia patients (40.9%; n=27 versus 21.1%; n=75), translating into a 2.5-fold increased odds ratio (P<0.001). Multivariable analyses identified hyponatremia as an independent predictor of in-hospital mortality (odds ratio, 2.2; 95% confidence interval, 1.05-4.62; P=0.037). Within 90 days after ICH, hyponatremia patients surviving hospital stay were also at greater risk of death (odds ratio, 4.8; 95% confidence interval, 2.1-10.6; P<0.001); thereafter, mortality rates were similar. Conclusions-Hyponatremia was identified as an independent predictor of in-hospital mortality with a fairly high prevalence in spontaneous ICH patients. The presence of hyponatremia at hospital admission is related to an increased short-term mortality in patients surviving acute care, possibly reflecting a preexisting condition that is linked to worse outcome due to greater comorbidity. Correction of hyponatremia does not seem to compensate its influence on mortality, which strongly warrants future research. (Stroke. 2014;45:1285-1291.)
H yponatremia is the most frequently encountered electrolyte disturbance in patients in critical care and has been associated with increased mortality and morbidity in various diseases such as heart failure, cirrhosis, or chronic kidney disease. [1] [2] [3] [4] Roughly, one third of these patients present with preexisting hyponatremia, and there is also a high incidence of hyponatremia developing during hospital stay. 2, 3, 5 In general, there are no large prospective randomized controlled trials investigating the clinical impact of hyponatremia. For neurointensive care patients, only few studies are available focussing on postoperative neurosurgical patients, traumatic brain injury, and subarachnoid hemorrhage supporting the associations of hyponatremia with increased mortality, longer hospital stay, and raised complications. [6] [7] [8] [9] Pathophysiological mechanisms that link hyponatremia to outcome in neurointensive care include the development of cerebral edema, seizures, and delayed cerebral infarctions. In these patients, hyponatremia may be caused by the syndrome of inappropriate antidiuretic hormone secretion and cerebral salt wasting syndrome. 6, 8, 10 These aspects conclude that hyponatremia may rather be developing than preexisting, possibly considering hyponatremia as bystander just reflecting the disease severity. Beyond these aspects, recent research has strengthened our understanding of hyponatremia itself as a potentially preexisting marker influencing outcome negatively. 11, 12 For ischemic or hemorrhagic stroke (intracerebral hemorrhage, ICH), there are no data available. This study is the first
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to investigate the prevalence of hyponatremia, its associations with clinical characteristics, and its influence on mortality and functional outcome in patients with spontaneous ICH.
Methods

Patient Selection
The study was approved by the local ethics committee of Friedrich-Alexander University Erlangen-Nuremberg, Germany. All consecutive spontaneous ICH patients admitted to the Department of Neurology during a 5-year period (2006-2010) were retrospectively analyzed from our prospective institutional database (n=464). Secondary ICH etiologies were excluded, that is, ICH related to anticoagulation, trauma, tumor, arteriovenous malformations, or ICH after acute thrombolysis or coagulopathy (platelet count <50.000/μL; International normalized ratio >1.4). Moreover, we excluded 13 patients that received larger fluid resuscitation (volume >1000 cm 3 ) or osmotherapy (mannitol or hypertonic saline infusions) before initial laboratory data were available (ie, hospital transferrals with missing initial laboratory data) as well as 29 patients that were lost to follow-up. Of all analyzed patients 37.4% (n=158) were transferred from peripheral hospitals, and the remaining 264 patients were direct admissions. Of all transferred patients, exclusively initial laboratory data from peripheral hospitals were used. Hence, 422 patients of central European descent remained for final analysis.
Parameter Acquisition
Data of all patients was retrieved from our institutional prospective database and reviewed for demographics, previous medical history, imaging, and in-hospital parameters (Glasgow Coma Scale, National Institutes of Health Stroke Scale, ICH score, blood pressure, mechanical ventilation, length of stay, external ventricular drainage for hydrocephalus, diagnosis of pneumonia, urinary tract infection, and sepsis according to established criteria). [13] [14] [15] Initial laboratory parameters were selected from our laboratory database. Anemia on admission was evaluated and defined as previously described. 16 Hyponatremia was defined as Na <135 mEq/L 5 and was corrected using 0.9% sodium infusions or hypertonic saline infusions (NaCl, 3%) targeting an increase of ≤8 mg/dL per 24 hours.
Outcome Measures
Mortality was assessed during hospital stay and followed up until 1 year after hospital discharge. Functional outcome was analyzed at 90 days and 1 year using the modified Rankin Scale (mRS). 17 Outcome measures were assessed by a standardized mailed questionnaire or semiquantitative phone interview (conducted whenever this questionnaire did not return <2-4 weeks) with patients, relatives, or primary care physicians. The interviews were performed by 2 scale-trained physicians certified for data collection on disability and quality of life (n=313; 74.2% by questionnaires and n=109; 25.8% by telephone interviews). Favorable outcome was defined as mRS=0 to 3 versus mRS=4 to 6.
Imaging
Diagnosis was made either by CT (SOMATOM Volume Zoom or SOMATOM Definition AS+; Siemens, Erlangen, Germany) or MRI (Sonata; 1.5 T; Siemens). Two neuroradiologists blinded to clinical data reviewed the scans independently, and in cases of discrepancies, a second consensus analysis was made. Hematoma growth (volume >33%) was determined on follow-up imaging, which was performed <24±6 hours. 18 Parenchymal ICH volume was calculated by the formula of ellipsoids (ABC/2), and different imaging modalities were compared by a validated conversion model. 19, 20 The Graeb score summation was used to score the extent of ventricular involvement. 21 Cerebral perihemorrhagic edema evolution was measured and quantified semiautomatically as described previously. 22
Statistical Analysis
Statistical analysis was performed with SPSS version 19.0 (SPSS Inc). The Kolmogorov-Smirnov and Shapiro-Wilk test was applied to determine the distribution of the data. The latter are presented as mean±SD (compared using the Student t test) or as median and interquartile range (compared using the Mann-Whitney U test) as appropriate. The Pearson χ 2 and Fisher exact tests were used to compare frequency distributions of categorized variables between hyponatremia and nonhyponatremia patients. The significance level, which was set at α=0.05, was corrected for multiple comparisons (type I error) by the Bonferroni method. Statistical tests were 2-sided. The relationship between hyponatremia and mortality was calculated using a log-rank test and visualized by Kaplan-Meier curve. Stepwise forward inclusion multivariable analyses were calculated to investigate (1) factors associated with hyponatremia (for more details, see Table I in the online-only Data Supplement) and (2) predictors for in-hospital mortality. Parameters reaching a statistical trend in univariable analysis (ie, P<0.1) were included into the multivariable models.
Results
Prevalence of Hyponatremia, Associated Factors, and Course of Sodium Levels
The prevalence of hyponatremia (Na <135 mEq/L) on hospital admission was 15.6% (n=66 of 422 ICH patients , and there was no association of serum sodium levels with time from symptom onset until admission ( Figure I in the online-only Data Supplement). Evaluated baseline characteristics and previous medical history are presented in Table 1 . Hyponatremia patients were showing statistical trends to a worse preadmission mRS (P=0.081), increased use of thiazide diuretics (P=0.095), and more frequent preexisting liver disease (P=0.005). However, all of these parameters did not reveal a significant association with hyponatremia on logistic regression modeling. Table 2 shows the comparison of clinical parameters between patients with and without hyponatremia documenting associations for hyponatremia with reduced osmolarity, decreased hemoglobin and hematocrit levels, as well as increased ICH score (all P<0.001). The assessment of radiological parameters revealed trends (after statistical correction) for an increased rate of intraventricular hemorrhage (IVH; hyponatremia 72.6% versus nonhyponatremia 55.6%; P=0.010) with higher Graeb scores (P=0.008). We hypothesized that IVH could lead to progressive hyponatremia over time due to the compression of midline cerebral structures including the pituitary gland; however, increasing time to presentation was not associated with sodium level in patients with or without IVH, and higher Graeb score was not associated with hyponatremia (P>0.05; Figure II in the online-only Data Supplement). To rule out that the increased occurrence of IVH among the group of hyponatremia patients reflects a major reason for the overall increased mortality of hyponatremia patients, Kaplan-Meier survival curves revealed that hyponatremia remained significantly associated with mortality despite the association of IVH with mortality ( Figure III in the online-only Data Supplement). Focussing on specific complications that are supposed to be related to hyponatremia, that is, edema formation, seizures, and infections, no significant differences could be elucidated between the compared groups. The 14-day course of median serum sodium levels is shown in Figure 1 . In >50% of patients, hyponatremia was corrected to normal range levels <24 hours. Sodium levels remained significantly different within the first 48 hours after admission. In essence, preexisting hyponatremia was corrected early, and thereafter median sodium levels remained normonatremic during hospital stay both in patients with and without initial hyponatremia.
Mortality
Graphical analysis (Kaplan-Meier survival curve from day 0 until day 90 [ie, <90 d]) is shown in Figure 2 . The median length of hospital stay was 11 days (95% confidence interval [CI], 1-28 days), and mortality difference at this time point is depicted by the dotted line. Hence, all-cause in-hospital mortality was roughly doubled (40.9% [n=27 in hyponatremia] versus 21.1% [n=75 in nonhyponatremia]; P<0.001). The evaluation of short-term mortality rates at 90 days revealed that overall 59.1% (n=39) of patients with hyponatremia versus 27.8% (n=99) of nonhyponatremia had died, translating into ≈4-fold increased 90-day mortality (odds ratio [OR], 3.8; 95% CI, 2.2-6.5; P<0.001). Of note, hyponatremia patients received significantly more often do-not-treat/do-not-resuscitate orders (18.2% versus 8.9%; P=0.025). To rule out that increased do-not-treat/do-not-resuscitate orders among the group of hyponatremia patients represented a major reason for the overall increased mortality in hyponatremia patients, all patients that received these orders were excluded for subanalyses. The presence of hyponatremia still remained significantly associated with mortality (OR, 2.8; 95% CI, 1.5-5.5; P=0.0015; for Kaplan-Meier survival curves after exclusion of those patients with withdrawal/withhold orders, see Figure IV in the onlineonly Data Supplement). Though withdrawal/withhold orders were more frequent in hyponatremia patients, there was no significant impact of these orders on increased in-hospital mortality of hyponatremia patients.
Functional Outcome
Short-and long-term functional outcome for the entire cohort is shown in Figure 3 . The proportion of patients with a favorable functional outcome was different among patients with and without hyponatremia (90 days: P=0.072; 1 year: P=0.033). Although functional outcome appeared to be driven mainly by in-hospital mortality, the fraction of hospital staysurviving patients who died thereafter but before 90 days was significantly higher in hyponatremia patients (18.2% versus 6.7%; OR, 4.8; 95% CI, 2.1-10.6; P<0.001). In contrast, the rate of 3-month survivors who died during 1-year follow-up was essentially the same in both groups (4.5% versus 6.5%; OR, 1.3; 95% CI, 0.4-4.5; P=0.723). This highlights that the significant difference in long-term functional outcome is mainly attributed to a higher in-hospital mortality and an early postdischarge (<90 days) mortality.
Hyponatremia Is Independently Associated With In-Hospital Mortality
In multivariable-adjusted analyses, hyponatremia was independently associated with increased ICH score (P=0.03) and with the presence of anemia at hospital admission (P=0.005; see Table I in the online-only Data Supplement). Multivariable analyses of predictors of in-hospital mortality showed that hyponatremia was independently associated with mortality (OR, 2.2; 95% CI, 1.05-4.6; P=0.04) controlling for age, ICH score, ICH volume, and IVH (Table 3) . Adding preexisting liver disease to the model did not influence the independent association of hyponatremia with in-hospital mortality (data not shown).
Discussion
This study represents the first analysis of hyponatremia in ICH patients and revealed that hyponatremia is a condition frequently associated with increased in-hospital and short-term mortality. Moreover, hyponatremia was identified as previously unrecognized independent predictor of in-hospital mortality. Some aspects emerge from the data.
The prevalence of hyponatremia in an ambulatory hospital care setting ranges between 11% to 21% and increases to 28.2% in acutely hospitalized patients. 12, 23 In neurointensive care, as shown here for ICH, 15.6% of patients presented with hyponatremia on admission, mirroring previous investigations of elderly community-dwelling populations. 24 Existing data on 
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May 2014 elderly patients propose chronically increased plasma vasopressin (arginine vasopressin, AVP) concentrations to account for hyponatremia, which is further complicated by impaired water excretory capacity, more frequent comorbidities, and polymedication. 23, 25 In line with existing data on subarachnoid hemorrhage or traumatic brain injury in which hyponatremia was linked to disease severity, 6 hyponatremia patients showed higher ICH scores and were more frequently anemic on admission, which has recently been independently associated with poorer functional long-term outcome. 16 Because there are no data from experimental or human studies reporting on hyperacute (minutes to hours) development of hyponatremia after neurological injury, we think that hyponatremia at hospital presentation rather reflects a preexisting condition (Figures I and II in the online-only Data Supplement). Hyponatremia has gained wide recognition as a factor being associated with a negative prognosis in a variety of conditions. 1, 3, 26, 27 In patients with decompensated heart failure, hyponatremia was present in 38% and went along with increased mortality, frequent hospital readmissions, and worse quality of life. 1, 3, 4 A postulated mechanism of hyponatremia influencing outcome also in neurointensive care could be its relation to an increased nonosmotic release of AVP caused by the overstimulation of the neurohumoral axis or by baroreceptor failure in elderly patients leading to cerebral hypoperfusion. 11, 28 After severe neurotrauma such as ICH, increased intracranial pressures and cerebral hypoperfusion may even aggravate secondary brain injury. Assuming that these mechanisms play a role in patients with ICH, increased AVP levels themselves could contribute to a reduced tolerance to cerebral hypoxia. 29 Potentially supporting this association in ICH, previous studies on the neurohormone copeptin, the C-terminal portion of provasopressin, which is cosecreted with AVP from the hypothalamus, 30 report that increased copeptin was a marker of poorer outcome, which was shown in subarachnoid hemorrhage, ischemic stroke, and also in patients with 
May 2014 ICH. [31] [32] [33] Despite these hypothetical pathophysiological considerations of hyponatremia-mediated effects on outcome, it remains unresolved whether hyponatremia simply represents a bystander of disease, that is, preexisting comorbidity or polymedication reflecting poorer overall status, which itself may be responsible for worse outcome. This aspect is even more important in light of the findings presented here, because all hyponatremia patients presented with hyponatremia on hospital admission rather than developed it during clinical course. Finally, up to now (and including this study), there is no evidence across various disciplines and diseases that correcting hyponatremia could result in improved clinical end points. 1, 11, 12 If AVP-mediated hyponatremia would be relevant in ICH, it has to be mentioned that a randomized controlled trial investigating treatment with vasopressin antagonist tolvaptan, on the one hand, revealed significantly increased sodium levels but, on the other hand, was not able to show effects on mortality. 34 From a neurological perspective beyond pontine myelinolysis, the correction of hyponatremia could even be harmful because cerebral adaption mechanisms may not work properly after neurological injury (ie, hypoxia), resulting in demyelinizations even at normal serum sodium levels. 11, 12 Vice versa, recent studies on cerebral edema evolution report on continuous hypertonic saline infusions with upper limit sodium levels targeted to be safe and possibly even beneficial in ICH. 35 Our study has several shortcomings, mainly its retrospective, single-center design that left this study unable to answer why hyponatremia patients showed increased in-hospital mortality. We have to assume that a precise analysis of preexisting comorbidities and polymedication possibly related to hyponatremia and outcome may have not been sufficiently achieved. This was because logistic regression analyses for these parameters did not reveal significant associations with hyponatremia and mortality. Moreover, the assessment of exact volume status at hospital admission (eu-, hypo-, or hypervolemic) and urine analysis was not realized because of the study design. Hypovolemic hyponatremia from post-ICH dehydration seems to be unlikely, because there was no correlation between sodium level and time from ICH symptom onset to admission ( Figure I in the online-only Data Supplement). In addition, the mailed questionnaires may have been answered wrongly with respect to the time point of follow-up and validity of mRS estimation, 36 and results may have been biased by patients lost to follow-up. Finally, correction for multiple comparisons (Bonferroni) may have decreased the chances of detecting false-negative but true associations.
In summary, hyponatremia is a common electrolyte abnormality in patients with spontaneous ICH and an independent predictor of in-hospital mortality. Hyponatremia seems to be a preexisting condition rather than developing acutely, being independently associated with anemia on admission. Correction of hyponatremia is appropriate although the mechanism of the association between hyponatremia and mortality is unclear.
SUPPLEMENTAL MATERIAL
Supplemental Title: Analyses for the associations of HN
Supplemental methods
Step-wise forward inclusion multivariable analysis was calculated to investigate factors that were independently associated with HN. Parameters reaching a statistical trend in univariable analysis (i.e. p<0.1) were included into the multivariable model. Moreover, graphical analyses were calculated for associations of HN. Two linear regression models were calculated with Serum sodium levels as dependent variable and time from symptom onset to admission as explanatory variable. The regression coefficient (R²) is shown within the figures and delineates the predictive association of the explanatory variables (0 = poor association; 1 = excellent association). Further, three Kaplan-Meier survival curves were calculated using a log-rank test for analysis of mortality over 90 days moreover including the statistical analysis of HN with in-hospital mortality presented as: Length of stay [LOS] as horizontal bold line with its corresponding 95% confidence interval (length of horizontal line), the median LOS is presented as vertical dotted line. Multivariable logistic regression model of parameters associated with HN. All parameters that showed a statistical trend (i.e. p < 0.1) in univariable testing were included into this stepwise forward regression model. Significant parameters after adjustment are expressed in bold.
Supplemental
Supplemental Figure I
Association of serum sodium levels with time from symptom onset until admission.
Serum sodium levels at hospital admission are graphically analyzed by linear regression analysis to determine the potential influence of poor per oral fluid intake at ictus over time (time from symptom onset until admission).
